Skip to main content
Journal cover image

Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research.

Publication ,  Journal Article
Chin, CT; Wang, TY; Anstrom, KJ; Zhu, B; Maa, J-F; Messenger, JC; Ryan, KA; Davidson-Ray, L; Zettler, M; Effron, MB; Mark, DB; Peterson, ED
Published in: Am Heart J
November 2011

BACKGROUND: Platelet inhibition is critical in reducing both short- and long-term atherothrombotic risks after acute myocardial infarction (MI), especially among patients managed with percutaneous coronary intervention (PCI). Currently available antiplatelet medications, including adenosine diphosphate (ADP) receptor inhibitors, have demonstrated variability in efficacy and safety in clinical trials, yet few studies have examined contemporary "real-world" approaches to platelet inhibition and associated outcomes. METHODS: TRANSLATE-ACS is a prospective observational study that will track up to 17,000 MI patients managed with PCI, from the inhospital to outpatient settings for up to 12 months postdischarge to provide a comprehensive picture of current treatment patterns and outcomes in routine clinical practice. TRANSLATE-ACS exemplifies a collaborative study design that efficiently builds upon a well-established PCI registry platform, and yet, through a systematic telephone interview follow-up process, provides important longitudinal clinical and economic follow-up capacity through 15 months after initial MI hospitalization. Furthermore, TRANSLATE-ACS incorporates a hospital-level, clustered, randomized substudy to investigate the impact of point-of-care platelet inhibition testing on subsequent patient management. Finally, TRANSLATE-ACS provides feedback through quarterly reports to participating sites on their care practices benchmarked to peer performance to support and promote longitudinal quality of cardiovascular care delivery. CONCLUSION: TRANSLATE-ACS not only addresses important clinical and scientific questions but also includes pioneering design features that will assist in the evolution of clinical registries.

Duke Scholars

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

November 2011

Volume

162

Issue

5

Start / End Page

844 / 851

Location

United States

Related Subject Headings

  • Research Design
  • Registries
  • Randomized Controlled Trials as Topic
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Patient Selection
  • Longitudinal Studies
  • Humans
  • Cardiovascular System & Hematology
  • Acute Coronary Syndrome
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chin, C. T., Wang, T. Y., Anstrom, K. J., Zhu, B., Maa, J.-F., Messenger, J. C., … Peterson, E. D. (2011). Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. Am Heart J, 162(5), 844–851. https://doi.org/10.1016/j.ahj.2011.08.021
Chin, Chee Tang, Tracy Y. Wang, Kevin J. Anstrom, Baojin Zhu, Jen-Fue Maa, John C. Messenger, Kelley A. Ryan, et al. “Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research.Am Heart J 162, no. 5 (November 2011): 844–51. https://doi.org/10.1016/j.ahj.2011.08.021.
Chin CT, Wang TY, Anstrom KJ, Zhu B, Maa J-F, Messenger JC, Ryan KA, Davidson-Ray L, Zettler M, Effron MB, Mark DB, Peterson ED. Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. Am Heart J. 2011 Nov;162(5):844–851.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

November 2011

Volume

162

Issue

5

Start / End Page

844 / 851

Location

United States

Related Subject Headings

  • Research Design
  • Registries
  • Randomized Controlled Trials as Topic
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Patient Selection
  • Longitudinal Studies
  • Humans
  • Cardiovascular System & Hematology
  • Acute Coronary Syndrome